US 8920812
Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
granted A61KA61K2039/5258A61K39/12
Quick answer
US patent 8920812 (Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS) held by Takeda Vaccines, Inc. expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/5258, A61K39/12, A61P, A61P11/00